News | News By Subject | News by Disease News By Date | Search News

Macular degeneration News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Regeneron (REGN) Bets $315 Million on Ocular Therapeutix (OCUL) for an Upgraded Form of Eylea     10/14/2016
San Diego’s Pfenex (PFNX) Regains Full Rights to PF582 and Announces Phase I/II Results     8/8/2016
Genentech (RHHBY) Partners Up with Novartis AG (NVS) on Ex-U.S. Rights to Wet AMD Candidate Fovista     11/17/2015
Avalanche Biotech (AAVL) Goes Back to Drawing Board, Performs More Preclinical Studies on Eye Drug     8/17/2015
Roche (RHHBY)'s Avastin Not Linked to Higher Risk of Blindness     8/14/2015
Lpath (LPTN) Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial     5/21/2015
Novartis AG (NVS) Accused of "Bullying" Doctors to Drop Trial of Cheaper Drugs     4/6/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech (RHHBY) Consultants     12/11/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Roche (RHHBY) Lucentis, Regeneron (REGN) Eylea Continue To Battle It Out In Eye Market     10/16/2014
Advanced Cell Technology Secures $30 Million Financing     7/3/2014
Small But Tenacious: Two Of San Diego's Emerging Biotechs Sophiris Bio Inc. (SPHS) And Lpath, Inc. (LPTN)     6/26/2014
Ohr Pharmaceutical (OHRP) Eye Drug Falls Short In Phase 2 Trial     6/24/2014

News from Around the Web
Implanted Telescope Helps Patients Overcome Macular Degeneration, VisionCare Reveals     8/26/2016
Broccoli May Help Treating Age-Related Vision Loss, Buck Institute for Age Research Study     7/7/2016
"Bionic Eye" Helps Man See After Decade Of Impaired Vision     7/23/2015
Smartphone Overuse May "Damage" Eyes, Say Opticians     4/1/2014
Compound Found in Rosemary Protects Against Macular Degeneration in Laboratory Model, Sanford-Burnham Medical Research Institute Study     11/28/2012
Compound Found in Rosemary Pprotects Against Macular Degeneration in Laboratory Model, Sanford-Burnham Medical Research Institute Study     11/27/2012
Omega-3 Fatty Acids Ward Off Macular Degeneration, Brigham and Women's Hospital Study     3/18/2011
Fish Oils May Protect Against Age-related Macular Degeneration, Harvard University Study     3/15/2011
Fish Oil May Thwart Advanced AMD, Johns Hopkins University Study     12/3/2010
American Academy of Ophthalmology: Bevacizumab Tops Anti-VEGF Choice in AMD, Duke University Study Finds     10/20/2010
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression     10/19/2010
AMD Treatments Don't Increase Risk of Mortality, Duke University Study     10/12/2010
Roche (RHHBY)'s Cancer Drug Could Save Eyesight of Tens of Thousands, Moorfields Eye Hospital Study     6/14/2010
Additional Genes Associated With Age-Related Macular Degeneration Identified At National Eye Institute     4/19/2010
Poor Night Vision May Predict Age-Related Eye Disease, University of Pennsylvania School of Medicine Study     11/14/2008

Press Releases
Exonate Closes Successful Funding Round - To Develop Eye Drops Treatment For Wet Age-related Macular Degeneration (Wet AMD)     12/1/2016
Opthea Completes Patient Enrolment In Phase 1/2A Wet AMD Clinical Trial     11/22/2016
Stealth Biotherapeutics Initiates Phase 1 Study Of Elamipretide In Dry Age-Related Macular Degeneration     11/14/2016
FDA Approves Genentech (RHHBY)'s Lucentis Pre-Filled Ranibizumab Syringe     10/17/2016
Regeneron (REGN) Faces Setback as Eylea Combo Drug Flunks Phase II Test     9/30/2016
Ophthotech Corporation (OPHT) Completes Patient Recruitment In Phase 3 Trial Of Fovista Anti-PDGF Therapy In Combination With Eylea Or Avastin In Wet Age-Related Macular Degeneration     6/20/2016
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Receives DSMB Approval To Start Second Patient Cohort In Clinical Trial For Dry-AMD     6/13/2016
BioTime (BTX) Announces $2.2 Million Grant For Further Development Of Dry-AMD Program     6/10/2016
SanBio, Inc. Granted Key Patent In Treatment For Macular Degeneration     5/16/2016
BioTime (BTX) Reports First Quarter Results And Recent Corporate Accomplishments     5/11/2016
Opthea Doses First Patient In Phase 2A Dose Expansion Study For OPT-302 In Wet AMD     5/5/2016
Ophthotech Corporation (OPHT) Reports First Quarter 2016 Financial And Operating Results     5/4/2016
Salutaris Medical Devices Wet AMD Distance Of Choroid Study Presented At Association for Research in Vision & Ophthalmology 2016     5/4/2016
USC Roski Eye Institute Researchers Publish Largest Eye Study Of Age-Related Macular Degeneration In Latino Population That Analyzes Impact On Quality Of Life     5/3/2016
RXi Pharma (RXII) And Thera Neuropharma Enter Into An Exclusive License Agreement For RXi's Self-Delivering RNAi (sd-rxRNA) Platform Targeting SOD1 To Develop Therapeutics For Neurodegenerative Diseases, Such As ALS (Lou Gehrig's Disease)     5/3/2016

//-->